HEALEY ALS Platform Trial Research Partners
For Industry/Pharma with ALS Pipeline
The HEALEY ALS Platform Trial will keep adding treatment arms. To learn more, pharma companies with a therapy for ALS can contact us via email.
Pioneering Breakthroughs Together
Collaboration is the key to our success. We believe sharing knowledge and expertise are essential to rapidly bringing innovative therapies to patients. That’s why we are partnering with leading industry and academic institutions to launch the first platform trial for ALS and share information with our peers to accelerate therapeutic innovation. To join us, email HEALEYALSPlatform@mgh.harvard.edu.
Our commitment to advancing treatment and therapies for individuals with ALS encourages us to the constant pursuit of new research partnerships and collaborations. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!
Investigator ResourcesLearn more about working with us in the collaborative HEALEY ALS Platform Trial:
HEALEY ALS Platform Trial Master Protocol
Regimen Specific Appendix Template
Request for Proposals
Confidentiality Agreement Template
Platform Trial Request for Proposals
Applications are now open for investigational products to be included in the HEALEY ALS Platform Trial.
Support the Sean M. Healey and AMG Center for ALS
Your support helps us provide excellent patient care today, and expands the boundaries of what will be possible in the future.
Platform Trial Informational Industry Webinar
Learn about the trial's operational structure and how your company can partner with the Healey Center to test new investigational products for ALS.
Join Our Quest
Join these people and organizations in supporting our quest to find a cure for ALS.